BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,511 | -1.5% | 6,852 | -2.0% | 0.00% | – |
| Q2 2023 | $49,238 | -11.7% | 6,994 | +4.7% | 0.00% | -100.0% |
| Q1 2023 | $55,736 | -12.4% | 6,683 | +20.6% | 0.00% | 0.0% |
| Q4 2022 | $63,634 | -9.1% | 5,543 | -0.7% | 0.00% | 0.0% |
| Q3 2022 | $70,000 | +45.8% | 5,582 | +24.0% | 0.00% | 0.0% |
| Q2 2022 | $48,000 | -34.2% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $73,000 | +17.7% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $62,000 | -4.6% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $65,000 | -8.5% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $71,000 | +54.3% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $46,000 | +35.3% | 4,501 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | +126.7% | 4,501 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | -28.6% | 4,501 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | +133.3% | 4,501 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | -43.8% | 4,501 | 0.0% | 0.00% | – |
| Q4 2019 | $16,000 | +23.1% | 4,501 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | -23.5% | 4,501 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -54.1% | 4,501 | +0.0% | 0.00% | -100.0% |
| Q1 2019 | $37,000 | +2.8% | 4,500 | -0.0% | 0.00% | 0.0% |
| Q4 2018 | $36,000 | +5.9% | 4,501 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $34,000 | +30.8% | 4,501 | +0.0% | 0.00% | – |
| Q2 2018 | $26,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |